What determines when Americans reclaim their ‘liberty’? Here is Dr. Fauci’s answer

Dr. Anthony Fauci testifies Thursday before the House Select Subcommittee on the Coronavirus Crisis.

Getty Images

During a House Select Subcommittee on the Coronavirus Crisis hearing on Thursday, Dr. Anthony Fauci, one of the top U.S. health officials on the COVID-19 pandemic, drew a road map for the country’s return to relative normality.

“What determines when?” Rep. Jim Jordan, a Republican from Ohio, challenged Fauci. The congressman said restrictions on movements and closures of businesses had impinged upon people’s rights to go to church and even leave their homes. He called it a year-plus-long loss of liberty.

‘We would have liked to see it go all the way down to a very, very low level arbitrarily. We don’t know what that number is — probably less than 10,000 per day.’

Fauci, the director of the National Institute of Allergy and Infectious Diseases, replied, “You’re indicating liberty and freedom. I look at it as a public health measure to prevent people from dying and going to the hospital.”

“My message, Congressman Jordan, is to get as many people vaccinated as quickly as we possibly can to get the level of infection in this country low, [such] that it is no longer a threat. That is when, and I believe when that happens, you will see,” he said.

Rep. Jim Jordan, a Republican from Ohio, challenged Fauci at Thursday’s subcommittee hearing to state explicitly when the U.S. public health situation would be sufficiently improved that curbs on “liberty” could be lifted. Fauci said Jordan was ranting.


“Right now, we have about 60,000 infections a day, which is a very large risk for a surge,” Fauci added. “We’re not talking about liberties. We’re talking about a pandemic that has killed 560,000 Americans. That’s what we’re talking about.”

He continued: “We would have liked to see it go all the way down to a very, very low level arbitrarily. We don’t know what that number is — probably less than 10,000 per day. We’re at a critical turning point. Every day we get better and better at being able to control it.”

As of Monday, there have been 567,217 COVID-related deaths in the U.S.

Currently, 25.4% of the U.S. population has been fully vaccinated, and, the Centers of Disease Prevention told CNN, 5,800 vaccinated people have still contracted COVID-19. Of these “breakthrough cases,” 74 people died, and several became seriously ill.

To put that 5,800 in context. Out of the 84.2 million Americans that have currently been vaccinated as of Monday morning, that equates to a 0.007% rate of breakthrough cases, and suggests that vaccination 99.993% effective.

Also Thursday, Pfizer CEO Albert Bourla told CNBC that people will likely require a third vaccine dose after 12 months, and potentially annual vaccinations thereafter. When asked about the prospects for a next-generation vaccine that can fend off emerging variants of the coronavirus SARS-CoV-2, Fauci told the hearing that the endgame was a universal vaccine, the business-news channel reported.

Pfizer CEO Albert Bourla told CNBC that people will likely require a third vaccine dose after 12 months, and potentially annual vaccinations thereafter.

“There are a number of ways of doing that,” he said. “We have important and new platform technologies, and we believe for example that we can apply the mRNA technology to get to that goal of getting a broad response against all possible variants.”

Fauci has in the past said that if the U.S. achieves 70% to 85% of the population vaccinated, that would equate to good “herd immunity,” and the country should start to see a return to normality by the fall. That, of course, may depend on individuals’ age, circumstances and underlying conditions.

The Food and Drug Administration and the Centers for Disease Control and Prevention recommended a pause in the use of the Johnson & Johnson vaccine this week as they examine six severe cases of blood clots among the roughly 7.4 million people who’ve taken it.

The pause was extended late Wednesday so that government scientists can gather and analyze more data.

On Wednesday, a 59-year-old woman — who previously had coronary artery disease — and 25-year-old man also developed blood clots: 7 of those 8 people who had taken the J&J had blood clots in the brain.

That equates to a 0.00009% risk, assuming the J&J vaccine was the cause. To put that in perspective, up to 0.1% of women are at risk of a blood clot from the contraceptive pill. The risk of a blood clot on a long-haul flight is 3% to 12%.

What’s more, the risk of blood clots soars with severe cases of COVID-19. “Overall, 20% of the COVID-19 patients were found to have blood clots in the veins, and among patients in the intensive care unit, that statistic increased to 31%,” according to a study from UC San Diego Health.

That said, there are many reasons why people get blood clots: family history, lifestyle, hypertension and obesity are just a few. Plus, the kinds of blood clots associated with the J&J vaccine are different from those related to contraceptives.

The vaccine from Johnson & Johnson unit
 Janssen is an adenovirus vector-based vaccine that only requires one shot. Clinical trials showed it had 72% efficacy in the U.S.

J&J has also paused its rollout in Europe.

The two-shot mRNA-based vaccines made by Pfizer
with German partner BioNTech SE
 and Moderna
 make up the majority of shots administered in the U.S., with clinical data pointing to efficacy rates in the mid-90s. Mayo Clinic research puts their “real world” effectiveness at closer to 88.7%.

As of Monday morning, 31.7 million people have been infected by the novel coronavirus first identified in Wuhan, China, late in 2019, according to Johns Hopkins University. Worldwide, more than 3 million people have died from the disease.

: As Kerry secures climate pledge with China, here’s what else to watch for at Biden’s Earth Day summit

Previous article

: Here’s what we know about COVID-19 vaccine side effects in women

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News